QuickView for PEA3-type ETS-domain transcription factor, N-terminal (biogroup)

1. A375, A549, H3122, PC-9, NCI-N87 and RT-112 cells treated with THZ1 and/or tyrosine kinase inhibitor
2. Lung cancer cells treated with ARS-1620 compound or with trametinib
3. Kidney progenitor tissue from E13 rat embryos
4. NSLC PC-9 cells treated with and selected for resistance to EGFR inhibitors gefitinib and WZ40002
5. Neural 3D tissue constructs from H1 ESC-derived precursor cells treated with neurotoxic chemicals

There were no matches for PEA3-type ETS-domain transcription factor, N-terminal

There were no clinical trials for PEA3-type ETS-domain transcription factor, N-terminal